Análisis

Tracxn reports that 23 firms developing automated cell‑therapy manufacturing have raised $1.1 billion across 34 rounds up to April 24.

Spherix analyst Jim Hickey attributes Novo Nordisk's oral Wegovy's swift market adoption to brand familiarity, outpacing Lilly's oral GLP‑1 candidate Foundayo.

Pfizer finalized a $10.5 billion, 12‑drug oncology partnership with Innovent Biologics in less than five months, despite facing internal stress tests.

Drugmakers are shifting focus to market themselves as well as their medicines as they become more prominent in health and cultural discussions.

AbbVie and J&J dominate U.S. drug advertising spend, while Eli Lilly and Novo Nordisk lead in organic AI citations.

GSK has aired its first direct-to-consumer television commercial for Exdensur, its asthma treatment expected to become a blockbuster.

A concise guide to the 95 Semaglutide suppliers on Pharmacountry, highlighting key sourcing regions and buyer considerations.

China, India, Italy, Germany, and the United States together account for over two‑thirds of active suppliers in Manufacturing Equipment & Utilities on Pharmacountry.